AstraZeneca’s Soriot on cures for pharma ills
from The Big View Hosted by Reuters
The $208 bln drugmaker’s CEO is celebrating 10 years at the helm. In this edition of the Exchange podcast, he explains why after quadrupling the company’s share price, there is more to do. He also delves into Chinese competition and the consequences of caps on U.S. drug prices.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The Big View?
This episode is 50 minutes long.
When was this The Big View episode published?
This episode was published on August 30, 2022.
Can I download this The Big View episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.